Advertisement
Advertisement
U.S. markets open in 4 hours 30 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Castle Biosciences, Inc. (CSTL)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
41.92+2.40 (+6.07%)
At close: 04:00PM EST
41.92 0.00 (0.00%)
After hours: 04:01PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Previous Close39.52
Open39.46
Bid0.00 x 800
Ask0.00 x 900
Day's Range39.46 - 42.06
52 Week Range39.34 - 107.69
Volume626,874
Avg. Volume193,085
Market Cap1.061B
Beta (5Y Monthly)0.46
PE Ratio (TTM)N/A
EPS (TTM)-1.24
Earnings DateNov 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est87.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CSTL

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Castle Biosciences, Inc.
    Analyst Report: QIAGEN N.V.Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates over 85% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (44% of 2020 sales), followed by EMEA (36%) and Asia-Pacific (19%).
    Rating
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more
Advertisement
Advertisement